Market Access/ News/ News After Scotland says no, NICE backs Lilly’s Retsevmo for lung cancer Phil Taylor Blueprint Medicines, Eli Lilly, Gavreto, HEOR, NICE, Non-small cell lung cancer, RET inhibitor, Retsevmo, Roche 0 Comment Eli Lilly’s RET inhibitor Retsevmo can now be prescribed on the NHS for people with RET fusion-positive advanced Share X After Scotland says no, NICE backs Lilly’s Retsevmo for lung cancer https://pharmaphorum.com/news/after-scotland-says-no-nice-backs-lillys-retsevmo-for-lung-cancer/